Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3Q8IB87
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 7 |
GO:0006793 | phosphorus metabolic process | 3 | 7 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0016310 | phosphorylation | 5 | 7 |
GO:0019538 | protein metabolic process | 3 | 7 |
GO:0036211 | protein modification process | 4 | 7 |
GO:0043170 | macromolecule metabolic process | 3 | 7 |
GO:0043412 | macromolecule modification | 4 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 7 |
GO:0003824 | catalytic activity | 1 | 7 |
GO:0004672 | protein kinase activity | 3 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0005524 | ATP binding | 5 | 7 |
GO:0016301 | kinase activity | 4 | 7 |
GO:0016740 | transferase activity | 2 | 7 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 7 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 7 |
GO:0017076 | purine nucleotide binding | 4 | 7 |
GO:0030554 | adenyl nucleotide binding | 5 | 7 |
GO:0032553 | ribonucleotide binding | 3 | 7 |
GO:0032555 | purine ribonucleotide binding | 4 | 7 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 7 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 7 |
GO:0036094 | small molecule binding | 2 | 7 |
GO:0043167 | ion binding | 2 | 7 |
GO:0043168 | anion binding | 3 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:0097367 | carbohydrate derivative binding | 2 | 7 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 7 |
GO:1901265 | nucleoside phosphate binding | 3 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 219 | 223 | PF00656 | 0.549 |
CLV_C14_Caspase3-7 | 480 | 484 | PF00656 | 0.345 |
CLV_NRD_NRD_1 | 245 | 247 | PF00675 | 0.320 |
CLV_NRD_NRD_1 | 388 | 390 | PF00675 | 0.367 |
CLV_NRD_NRD_1 | 454 | 456 | PF00675 | 0.395 |
CLV_PCSK_KEX2_1 | 191 | 193 | PF00082 | 0.363 |
CLV_PCSK_KEX2_1 | 245 | 247 | PF00082 | 0.345 |
CLV_PCSK_KEX2_1 | 309 | 311 | PF00082 | 0.315 |
CLV_PCSK_KEX2_1 | 320 | 322 | PF00082 | 0.315 |
CLV_PCSK_KEX2_1 | 454 | 456 | PF00082 | 0.453 |
CLV_PCSK_KEX2_1 | 556 | 558 | PF00082 | 0.345 |
CLV_PCSK_PC1ET2_1 | 191 | 193 | PF00082 | 0.363 |
CLV_PCSK_PC1ET2_1 | 309 | 311 | PF00082 | 0.301 |
CLV_PCSK_PC1ET2_1 | 320 | 322 | PF00082 | 0.341 |
CLV_PCSK_PC1ET2_1 | 556 | 558 | PF00082 | 0.345 |
CLV_PCSK_SKI1_1 | 204 | 208 | PF00082 | 0.523 |
CLV_PCSK_SKI1_1 | 236 | 240 | PF00082 | 0.508 |
CLV_PCSK_SKI1_1 | 245 | 249 | PF00082 | 0.313 |
CLV_PCSK_SKI1_1 | 298 | 302 | PF00082 | 0.368 |
CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.488 |
CLV_PCSK_SKI1_1 | 455 | 459 | PF00082 | 0.345 |
CLV_PCSK_SKI1_1 | 543 | 547 | PF00082 | 0.395 |
CLV_PCSK_SKI1_1 | 570 | 574 | PF00082 | 0.513 |
DEG_SPOP_SBC_1 | 131 | 135 | PF00917 | 0.656 |
DOC_CKS1_1 | 374 | 379 | PF01111 | 0.395 |
DOC_MAPK_gen_1 | 243 | 250 | PF00069 | 0.287 |
DOC_MAPK_gen_1 | 36 | 43 | PF00069 | 0.456 |
DOC_MAPK_MEF2A_6 | 524 | 532 | PF00069 | 0.395 |
DOC_PP2B_LxvP_1 | 110 | 113 | PF13499 | 0.600 |
DOC_USP7_MATH_1 | 131 | 135 | PF00917 | 0.683 |
DOC_USP7_MATH_1 | 473 | 477 | PF00917 | 0.328 |
DOC_USP7_MATH_1 | 78 | 82 | PF00917 | 0.779 |
DOC_USP7_MATH_2 | 68 | 74 | PF00917 | 0.560 |
DOC_USP7_UBL2_3 | 149 | 153 | PF12436 | 0.706 |
DOC_WW_Pin1_4 | 373 | 378 | PF00397 | 0.457 |
DOC_WW_Pin1_4 | 403 | 408 | PF00397 | 0.375 |
LIG_14-3-3_CanoR_1 | 204 | 211 | PF00244 | 0.495 |
LIG_14-3-3_CanoR_1 | 36 | 41 | PF00244 | 0.458 |
LIG_14-3-3_CanoR_1 | 454 | 460 | PF00244 | 0.343 |
LIG_14-3-3_CanoR_1 | 561 | 567 | PF00244 | 0.395 |
LIG_Actin_WH2_2 | 293 | 311 | PF00022 | 0.319 |
LIG_APCC_ABBA_1 | 349 | 354 | PF00400 | 0.395 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.522 |
LIG_BIR_III_4 | 469 | 473 | PF00653 | 0.320 |
LIG_BRCT_BRCA1_1 | 1 | 5 | PF00533 | 0.522 |
LIG_BRCT_BRCA1_1 | 310 | 314 | PF00533 | 0.320 |
LIG_BRCT_BRCA1_1 | 515 | 519 | PF00533 | 0.395 |
LIG_BRCT_BRCA1_1 | 538 | 542 | PF00533 | 0.315 |
LIG_BRCT_BRCA1_1 | 564 | 568 | PF00533 | 0.395 |
LIG_BRCT_BRCA1_2 | 564 | 570 | PF00533 | 0.345 |
LIG_deltaCOP1_diTrp_1 | 420 | 429 | PF00928 | 0.395 |
LIG_FHA_1 | 195 | 201 | PF00498 | 0.456 |
LIG_FHA_1 | 205 | 211 | PF00498 | 0.437 |
LIG_FHA_1 | 299 | 305 | PF00498 | 0.395 |
LIG_FHA_1 | 431 | 437 | PF00498 | 0.329 |
LIG_FHA_1 | 513 | 519 | PF00498 | 0.395 |
LIG_FHA_2 | 374 | 380 | PF00498 | 0.289 |
LIG_FHA_2 | 415 | 421 | PF00498 | 0.315 |
LIG_FHA_2 | 478 | 484 | PF00498 | 0.439 |
LIG_GBD_Chelix_1 | 253 | 261 | PF00786 | 0.395 |
LIG_LIR_Apic_2 | 401 | 407 | PF02991 | 0.315 |
LIG_LIR_Gen_1 | 120 | 131 | PF02991 | 0.640 |
LIG_LIR_Gen_1 | 212 | 221 | PF02991 | 0.453 |
LIG_LIR_Gen_1 | 27 | 37 | PF02991 | 0.490 |
LIG_LIR_Gen_1 | 356 | 367 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 2 | 8 | PF02991 | 0.571 |
LIG_LIR_Nem_3 | 212 | 217 | PF02991 | 0.524 |
LIG_LIR_Nem_3 | 27 | 32 | PF02991 | 0.489 |
LIG_LIR_Nem_3 | 34 | 40 | PF02991 | 0.428 |
LIG_LIR_Nem_3 | 356 | 362 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 435 | 441 | PF02991 | 0.395 |
LIG_LIR_Nem_3 | 521 | 526 | PF02991 | 0.294 |
LIG_LIR_Nem_3 | 539 | 545 | PF02991 | 0.315 |
LIG_LYPXL_yS_3 | 445 | 448 | PF13949 | 0.395 |
LIG_MYND_3 | 11 | 15 | PF01753 | 0.565 |
LIG_SH2_CRK | 37 | 41 | PF00017 | 0.510 |
LIG_SH2_SRC | 364 | 367 | PF00017 | 0.345 |
LIG_SH2_STAP1 | 251 | 255 | PF00017 | 0.395 |
LIG_SH2_STAP1 | 291 | 295 | PF00017 | 0.423 |
LIG_SH2_STAT5 | 142 | 145 | PF00017 | 0.649 |
LIG_SH2_STAT5 | 194 | 197 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.388 |
LIG_SH3_3 | 371 | 377 | PF00018 | 0.395 |
LIG_SH3_3 | 434 | 440 | PF00018 | 0.328 |
LIG_SH3_3 | 552 | 558 | PF00018 | 0.398 |
LIG_SH3_3 | 88 | 94 | PF00018 | 0.653 |
LIG_SUMO_SIM_par_1 | 231 | 237 | PF11976 | 0.395 |
LIG_SUMO_SIM_par_1 | 246 | 252 | PF11976 | 0.204 |
LIG_SUMO_SIM_par_1 | 365 | 371 | PF11976 | 0.368 |
LIG_WRC_WIRS_1 | 542 | 547 | PF05994 | 0.395 |
MOD_CK1_1 | 101 | 107 | PF00069 | 0.757 |
MOD_CK1_1 | 119 | 125 | PF00069 | 0.532 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.620 |
MOD_CK1_1 | 152 | 158 | PF00069 | 0.704 |
MOD_CK1_1 | 406 | 412 | PF00069 | 0.343 |
MOD_CK1_1 | 506 | 512 | PF00069 | 0.329 |
MOD_CK1_1 | 513 | 519 | PF00069 | 0.328 |
MOD_CK1_1 | 537 | 543 | PF00069 | 0.319 |
MOD_CK2_1 | 373 | 379 | PF00069 | 0.285 |
MOD_CK2_1 | 541 | 547 | PF00069 | 0.345 |
MOD_Cter_Amidation | 189 | 192 | PF01082 | 0.404 |
MOD_GlcNHglycan | 137 | 140 | PF01048 | 0.702 |
MOD_GlcNHglycan | 283 | 286 | PF01048 | 0.258 |
MOD_GlcNHglycan | 310 | 313 | PF01048 | 0.369 |
MOD_GlcNHglycan | 327 | 330 | PF01048 | 0.369 |
MOD_GlcNHglycan | 353 | 358 | PF01048 | 0.443 |
MOD_GlcNHglycan | 473 | 476 | PF01048 | 0.442 |
MOD_GlcNHglycan | 501 | 504 | PF01048 | 0.417 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.769 |
MOD_GlcNHglycan | 80 | 83 | PF01048 | 0.697 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.747 |
MOD_GSK3_1 | 149 | 156 | PF00069 | 0.800 |
MOD_GSK3_1 | 296 | 303 | PF00069 | 0.506 |
MOD_GSK3_1 | 394 | 401 | PF00069 | 0.452 |
MOD_GSK3_1 | 420 | 427 | PF00069 | 0.321 |
MOD_GSK3_1 | 473 | 480 | PF00069 | 0.462 |
MOD_GSK3_1 | 499 | 506 | PF00069 | 0.366 |
MOD_GSK3_1 | 537 | 544 | PF00069 | 0.395 |
MOD_N-GLC_1 | 135 | 140 | PF02516 | 0.797 |
MOD_NEK2_1 | 158 | 163 | PF00069 | 0.619 |
MOD_NEK2_1 | 296 | 301 | PF00069 | 0.352 |
MOD_NEK2_1 | 308 | 313 | PF00069 | 0.315 |
MOD_NEK2_1 | 352 | 357 | PF00069 | 0.336 |
MOD_NEK2_1 | 424 | 429 | PF00069 | 0.315 |
MOD_NEK2_1 | 471 | 476 | PF00069 | 0.303 |
MOD_NEK2_1 | 498 | 503 | PF00069 | 0.426 |
MOD_NEK2_1 | 57 | 62 | PF00069 | 0.513 |
MOD_NEK2_2 | 473 | 478 | PF00069 | 0.345 |
MOD_PIKK_1 | 513 | 519 | PF00454 | 0.395 |
MOD_PIKK_1 | 58 | 64 | PF00454 | 0.607 |
MOD_PKA_1 | 455 | 461 | PF00069 | 0.393 |
MOD_PKA_1 | 556 | 562 | PF00069 | 0.345 |
MOD_PKA_2 | 101 | 107 | PF00069 | 0.720 |
MOD_PKA_2 | 398 | 404 | PF00069 | 0.355 |
MOD_PKA_2 | 506 | 512 | PF00069 | 0.345 |
MOD_PKA_2 | 556 | 562 | PF00069 | 0.315 |
MOD_Plk_1 | 119 | 125 | PF00069 | 0.676 |
MOD_Plk_1 | 236 | 242 | PF00069 | 0.395 |
MOD_Plk_1 | 353 | 359 | PF00069 | 0.319 |
MOD_Plk_1 | 534 | 540 | PF00069 | 0.298 |
MOD_Plk_1 | 570 | 576 | PF00069 | 0.481 |
MOD_Plk_1 | 58 | 64 | PF00069 | 0.621 |
MOD_Plk_2-3 | 541 | 547 | PF00069 | 0.345 |
MOD_Plk_4 | 122 | 128 | PF00069 | 0.738 |
MOD_Plk_4 | 24 | 30 | PF00069 | 0.533 |
MOD_Plk_4 | 266 | 272 | PF00069 | 0.370 |
MOD_Plk_4 | 36 | 42 | PF00069 | 0.590 |
MOD_Plk_4 | 398 | 404 | PF00069 | 0.378 |
MOD_Plk_4 | 444 | 450 | PF00069 | 0.325 |
MOD_ProDKin_1 | 373 | 379 | PF00069 | 0.457 |
MOD_ProDKin_1 | 403 | 409 | PF00069 | 0.375 |
MOD_SUMO_rev_2 | 152 | 161 | PF00179 | 0.603 |
MOD_SUMO_rev_2 | 489 | 494 | PF00179 | 0.343 |
TRG_DiLeu_BaEn_2 | 540 | 546 | PF01217 | 0.395 |
TRG_DiLeu_BaLyEn_6 | 243 | 248 | PF01217 | 0.268 |
TRG_ENDOCYTIC_2 | 29 | 32 | PF00928 | 0.485 |
TRG_ENDOCYTIC_2 | 291 | 294 | PF00928 | 0.454 |
TRG_ENDOCYTIC_2 | 359 | 362 | PF00928 | 0.339 |
TRG_ENDOCYTIC_2 | 364 | 367 | PF00928 | 0.349 |
TRG_ENDOCYTIC_2 | 37 | 40 | PF00928 | 0.438 |
TRG_ENDOCYTIC_2 | 445 | 448 | PF00928 | 0.395 |
TRG_ENDOCYTIC_2 | 523 | 526 | PF00928 | 0.315 |
TRG_ER_diArg_1 | 245 | 247 | PF00400 | 0.320 |
TRG_ER_diArg_1 | 453 | 455 | PF00400 | 0.413 |
TRG_ER_diArg_1 | 494 | 497 | PF00400 | 0.483 |
TRG_Pf-PMV_PEXEL_1 | 245 | 249 | PF00026 | 0.258 |
TRG_Pf-PMV_PEXEL_1 | 321 | 325 | PF00026 | 0.195 |
TRG_Pf-PMV_PEXEL_1 | 383 | 388 | PF00026 | 0.345 |
TRG_Pf-PMV_PEXEL_1 | 439 | 444 | PF00026 | 0.345 |
TRG_Pf-PMV_PEXEL_1 | 460 | 464 | PF00026 | 0.345 |
TRG_Pf-PMV_PEXEL_1 | 55 | 59 | PF00026 | 0.478 |
TRG_Pf-PMV_PEXEL_1 | 93 | 97 | PF00026 | 0.656 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I436 | Leptomonas seymouri | 41% | 98% |
A4H6H6 | Leishmania braziliensis | 77% | 100% |
A4HUW6 | Leishmania infantum | 99% | 100% |
E9ANJ7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4QH29 | Leishmania major | 94% | 100% |